HomeCompareCB vs NDAQ

CB vs NDAQ: Dividend Comparison 2026

CB yields 1.19% · NDAQ yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NDAQ wins by $2.0K in total portfolio value
10 years
CB
CB
● Live price
1.19%
Share price
$325.35
Annual div
$3.88
5Y div CAGR
23.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.0K
Annual income
$1,241.17
Full CB calculator →
NDAQ
NDAQ
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NDAQ calculator →

Portfolio growth — CB vs NDAQ

📍 NDAQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBNDAQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CB + NDAQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CB pays
NDAQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CB
Annual income on $10K today (after 15% tax)
$101.37/yr
After 10yr DRIP, annual income (after tax)
$1,054.99/yr
NDAQ
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, CB beats the other by $290.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CB + NDAQ for your $10,000?

CB: 50%NDAQ: 50%
100% NDAQ50/50100% CB
Portfolio after 10yr
$27.0K
Annual income
$1,070.19/yr
Blended yield
3.96%
📊

Analyst Conviction Gap

Where Wall Street is split right now

CB
Analyst Ratings
1
Strong
22
Buy
18
Hold
2
Sell
Consensus: Buy
Price Target
$342.00
+5.1% upside vs current
Range: $305.00 — $373.00
Altman Z
1.4
Piotroski
7/9
NDAQ
Analyst Ratings
23
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$113.60
+127.2% upside vs current
Range: $108.00 — $120.00
Altman Z
2.5
Piotroski
9/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CB buys
0
NDAQ buys
0
No recent congressional trades found for CB or NDAQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBNDAQ
Forward yield1.19%4.00%
Annual dividend / share$3.88$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR23.5%5%
Portfolio after 10y$26.0K$28.0K
Annual income after 10y$1,241.17$899.19
Total dividends collected$5.2K$6.4K
Payment frequencyquarterlyquarterly
SectorFinancialsFinancials
Analyst consensusBuyBuy
Analyst price target$342.00$113.60

Year-by-year: CB vs NDAQ ($10,000, DRIP)

YearCB PortfolioCB Income/yrNDAQ PortfolioNDAQ Income/yrGap
1← crossover$10,847$147.28$11,120$420.00$273.00NDAQ
2$11,791$184.40$12,357$458.31$566.00NDAQ
3$12,848$231.35$13,721$499.76$873.00NDAQ
4$14,038$290.95$15,227$544.58$1.2KNDAQ
5$15,388$366.93$16,885$593.02$1.5KNDAQ
6$16,929$464.23$18,713$645.34$1.8KNDAQ
7$18,703$589.49$20,724$701.81$2.0KNDAQ
8$20,764$751.71$22,938$762.73$2.2KNDAQ
9$23,181$963.24$25,372$828.41$2.2KNDAQ
10$26,045$1,241.17$28,047$899.19$2.0KNDAQ

CB vs NDAQ: Complete Analysis 2026

CBFinancials

Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical, cyber risk, surety, and excess casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm and ranch property, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction risk; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual term life, group term life, medical and health, personal accident, credit life, universal life, and unit linked contracts. The company markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

Full CB Calculator →

NDAQFinancials

NDAQ is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NDAQ shares.

Full NDAQ Calculator →
📬

Get this CB vs NDAQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CB vs SCHDCB vs JEPICB vs OCB vs KOCB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.